BKS Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$4.88M Sell
37,608
-85
-0.2% -$10.3K 1.96% 8
2018
Q4
$4.36M Sell
37,693
-3,302
-8% -$369K 1.98% 10
2018
Q3
$4.4M Sell
40,995
-308
-0.7% -$30.8K 1.62% 16
2018
Q2
$3.52M Sell
41,303
-857
-2% -$70.4K 1.25% 20
2018
Q1
$3.26M Buy
42,160
+1,053
+3% +$84.8K 1.19% 23
2017
Q4
$3.47M Buy
41,107
+316
+0.8% +$26.9K 1.26% 21
2017
Q3
$3.49M Buy
40,791
+310
+0.8% +$25.4K 1.35% 20
2017
Q2
$3.33M Buy
40,481
+182
+0.5% +$14.8K 1.36% 19
2017
Q1
$3.39M Sell
40,299
-3,237
-7% -$259K 1.48% 17
2016
Q4
$3.2M Sell
43,536
-451
-1% -$33.6K 1.5% 16
2016
Q3
$3.53M Sell
43,987
-5
-0% -$400 1.63% 15
2016
Q2
$3.46M Sell
43,992
-1,845
-4% -$139K 1.78% 13
2016
Q1
$3.3M Buy
45,837
+2,229
+5% +$169K 1.72% 17
2015
Q4
$3.67M Buy
43,608
+2,077
+5% +$172K 1.89% 15
2015
Q3
$3.48M Sell
41,531
-2,350
-5% -$198K 1.93% 17
2015
Q2
$3.66M Sell
43,881
-1,202
-3% -$91.6K 1.75% 19
2015
Q1
$3.27M Buy
+45,083
New +$3.21M 1.56% 19

Other funds holding LLY

BKS Advisors's LLY Position: Q1 2019 in Review

BKS Advisors reduced its Eli Lilly (LLY) stake by 0.23% in Q1 2019, selling an estimated $10.3K and leaving 37,608 shares worth $4.88M. The position accounts for 1.96% of the portfolio, ranked #8.

BKS Advisors first reported a position in LLY in Q1 2015 and has held it in 17 quarters since. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • BKS Advisors held 37,608 shares of Eli Lilly worth $4.88M as of Q1 2019.
  • BKS Advisors sold 85 Eli Lilly shares in Q1 2019, an estimated $10.3K.
  • Eli Lilly made up 1.96% of BKS Advisors's portfolio in Q1 2019, its #8 holding.
  • BKS Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 17 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.